Based on 2 analysts offering 12 month price targets for Lakefront Biotherapeutics Nv
Min Forecast
$26.00-11.5%
Avg Forecast
$35.50+20.83%
Max Forecast
$45.00+53.17%
Should I buy or sell LKFT stock?
Based on 2 analysts offering ratings for Lakefront Biotherapeutics Nv.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LKFT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates LKFT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their LKFT stock forecasts and price targets.
Is Lakefront Biotherapeutics Nv Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: LKFT) stock is to Buy LKFT stock.
Out of 2 analysts, 0 (0%) are recommending LKFT as a Strong Buy, 1 (50%) are recommending LKFT as a Buy, 1 (50%) are recommending LKFT as a Hold, 0 (0%) are recommending LKFT as a Sell, and 0 (0%) are recommending LKFT as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year LKFT price target, the average LKFT price target is $35.50, with the highest LKFT stock price forecast at $45.00 and the lowest LKFT stock price forecast at $26.00.
On average, Wall Street analysts predict that Lakefront Biotherapeutics Nv's share price could reach $35.50 by Sep 23, 2027. The average Lakefront Biotherapeutics Nv stock price prediction forecasts a potential upside of 20.83% from the current LKFT share price of $29.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.